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Abstract
Inflammatory bowel disease (IBD) is a group of intestinal disorders that cause 
prolonged inflammation of digestive tract. Chronic inflammation results in Crohn’s 
disease (CD) and ulcerative colitis (UC). There is a disruption of homeostasis of 
various regulatory factors, for example, cohesive functioning of intestinal epithelial 
barrier, macrophages, and cellular mediators such as cytokines and chemokines. 
Natural products derived from plants based on traditional system of medicine have 
exhibited efficacy for UC and CD in experimental models and clinical trials. In the 
present review, current developments of natural products and herbs for the treat-
ment of IBD in the context of Indian traditional medicine have been highlighted. 
Two classes of Ayurvedic formulation, fermented preparations (Asava and Arishta) 
and Ghrita (preparations involving butter), are employed for the maintenance of 
intestinal disorders. Here, we discuss mainly about the fermented preparations, 
their main constituents, and correlations with modern findings. The way these 
fermented formulations are processed also affects the extraction of constituents 
in them. So, the correlation between the chemistry of the plant material (their 
constituents as well) with the IBD was done. These correlations may serve as a step 
forward to reduce the gap between modern system of medicine and traditional 
system of medicine.
Keywords: inflammatory bowel disease, traditional system of medicine,  
fermented preparations, gallotannins, ellagitannins
1. Introduction
Inflammatory bowel disease (IBD) is the intestinal disorder induced by chronic 
gastrointestinal inflammation. Crohn’s disease (CD) and ulcerative colitis (UC) 
are global health problems, with the highest incidence and a prevalence rate of 
0.5–1.0% in Europe [1]. The incidence of IBD is increasing dramatically in Asian 
countries, especially in China. There is rising incidence and prevalence of inflam-
matory bowel disease in India, topping the Southeast Asian (SEA) countries [2]. 
IBD is relatively complex disease that involves numerous factors such as commensal 
flora, genetic factors, immune system dysfunction, and environmental risk factors 
[3]. The human gastrointestinal tract serves as the first-line sensor, and defense 
against external environment stimuli is exposed to the external environment, 
particularly to bacterial antigens released from resident microbiota. It is the chronic 
inflammation in the intestinal surface that first leads to the development of UC, 
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which can progress into CD and/or colon cancer [3]. Advances have been achieved 
in understanding the pathogenesis of IBD in the past few years, yet exact mecha-
nisms remain to be elucidated. Patients usually suffer from severe pain, diarrhea, 
abscesses, fistulas, abdominal pain, and stenosis. Thus the development of effective 
treatments and/or reducing the symptoms of patients with IBD is urgently needed. 
The current mainstream management of IBD includes antibiotics, corticosteroids, 
thiopurines, anti-tumor necrosis factor (TNF) antibodies, and aminosalicylates 
[2]. They have severe side effects such as diarrhea, nausea, vomiting, headache, 
and osteoporosis when used for the long term. One-third of CD patients undergo 
surgery after long-term use of these mainstream treatments [4].
The Indian System of Medicine which mainly comprises of Ayurveda (meaning 
the science of life) is one of the oldest systems of medicine in India. This system of 
using natural resources for better health was developed through the experimenta-
tion and experiences of day-to-day lifestyle of Indian people. Evolution of Ayurveda 
and plant-based remedies for health care through day-to-day life experiences is a 
part of cultural heritage of India. There is class of Ayurveda fermented prepara-
tions called Asava and Arishta mainly intended for intestinal disorders. These weak 
alcoholic preparations are more appreciated because of their quick action and high 
preserving qualities. These preparations are made by soaking the drugs, either 
powder form or in the form of decoction in a solution of sugar or jaggery, as the 
case may be for a specified period of time, during which it undergoes fermentation. 
It facilitates dissolution of active principles and acts as a preservative. For Arishta 
preparation, the drugs mentioned in the text are coarsely powdered, and the decoc-
tion is prepared by boiling the plant material in a specified volume of water till it is 
reduced to one-fourth of the original volume. The decoction is filtered using muslin 
cloth. Jaggery as prescribed in formula is added and dissolved. Drugs indicated as 
prakshepa dravyas (plant material added after preparing decoction) are finely pow-
dered and added. At the end Woodfordia fruticosa (Dhataki pushpa) if mentioned 
is added. The container is then sealed and kept for fermentation and monitored 
regularly. After the fermentation is over, the fluid is decanted without disturbing 
the sediment. The decanted preparation is then kept for maturation for 2 weeks. 
The fine particles in the decanted preparation settle down (Figure 1) [5, 6].
The present review mainly discusses the fermented preparations used in 
Ayurveda for the intestinal disorders and correlates the constituents used for the 
same. For the preparation of formulations in ancient times, mainly decoctions were 
used, and then they were preserved by some processing methods, as fermenta-
tion in the case of Asava and Arishta. During the making of formulations, it is the 
water-soluble ingredients that are mainly extracted to water, and during fermenta-
tion they are transformed fit for the body to be absorbed and are medicinally active. 
The formulations (Parthadyarishta, Abhayarishta, and Jirakadyarishta) have shown 
certain chemical changes during fermentation due to which the desired marker 
constituents in the decoction are transformed: polyphenolics to their monomeric 
counterparts and glycosides to their respective aglycones [7–9]. HPLC analysis 
of the selected formulations revealed that it is the polyphenolics which are easily 
decocted into water and they form the major constituent of these liquid oral for-
mulations. There is also a breakdown of high molecular weight polyphenolics into 
the low molecular weight phenolics as evident from the quantitative analysis of the 
formulations. The changes in marker concentrations during fermentation also affect 
the antioxidant activity of the decoction and formulation [7–9]. Major constituents 
in these formulations based on their analysis have revealed the presence of polyphe-
nolics (gallotannins and ellagitannins), flavonoids, 5- HMF, and phenolic glyco-
sides, and constituents of jaggery formed the major constituents in the formulation. 
These constituents are correlated with modern finding in next section.
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2.  Major constituents present in fermented preparations and correlation 
with inflammatory bowel disease
2.1 Gallotannins
Gallotannins are a major constituent of plant materials used for the preparation 
of fermented preparation Abhayarishta. The pericarp of Terminalia chebula fruit 
is used in the preparation which is rich in hydrolyzable tannins and is reported to 
contain the following constituents: chebulic acid (1), gallic acid (2), ethyl gallate 
(3), polygalloyl derivatives (4–6), chebulinic acid (7), chebulanin (7a), chebulagic 
acid (8), terchebin (9), and terchebulin (10). During the making of formulation, 
pericarp powder is boiled in water till the volume is reduced to one- fourth, and 
this process mainly decocts the hydrolyzable tannins. During fermentation these 
gallotannins are fermented to their monogalloyl and digalloyl derivatives (5) and 
other counterparts (chebulic acid (1) in case of T. chebula). The fermented counter-
parts in case of their preparations have shown more antioxidant activity [7]. They 
may have very good effect on IBD also as have shown to good inflammatory agents. 
For example, chebulic acid (1) inhibits TNF-α, TNF-α, IL-1β, and IL-6 as well as 
enhances antioxidant detoxification defensing mediators such as HO-1 and NQO1 
expression, through ERK/Nrf2 signaling in HUVEC [10, 11]. It may be noted that 
tannins in case of T. chebula are of chebuloyl derivative [12], and during fermenta-
tion 7, 7a, and 8 will be hydrolyzed in acidic conditions to chebulic acid (1). It is also 
one of the major constituents in the formulation Abhayarishta [7]. Other constitu-
ents formed in final processed formulation during fermentation were monogalloyl 
derivatives and digalloyl derivative. This could be attributed to the presence of free 
galloyl group at anomeric carbon that makes chebulinic acid (7) and chebulagic acid 
(8) susceptible for cleavage [13]. Moreover, the amount of chebulinic acid (7) in 
decoction was found to be less (which is normally 2–4% of total dry weight of plant 
material). The reason for this may be the possible hydrolysis of the chebulinic acid 
(7) during boiling (as simple boiling resulted in hydrolysis) or less extraction of 
the same due to its hydrophobic properties resulting from free galloyl groups [13]. 
Ethyl gallate (3) and gallic acid (1) were formed as hydrolytic products and etha-
nolysis of tannic acid (Figures 2 and 3). These fermentation products had better 
Figure 1. 
Method of preparation of fermented preparations in Ayurveda.
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radical scavenging activity [7], and among them gallic acid (1) has shown to induce 
ROS-dependent apoptosis and inhibited the growth of colon cancer cells [14]. These 
formulations are used as nutraceuticals in the Indian subcontinent [15], and the 
constituents present in the formulation (or formed during the fermentation) have 
good anti-inflammatory properties as discussed above.
2.2 Ellagitannins
Ellagitannins are the other major phytoconstituents that are extracted during the 
boiling/maceration with water. This is mainly due to the presence of hexahydroxy-
diphenic (HHDP) moiety in ellagitannins [13]. Their extractability in water is more 
than the gallotannins. Terchebulin (9), punicalagin (10), and punicalin (11) are the 
major ellagitannins present in decoction and are fermented to increase concentration of 
ellagic acid in the final formulation [7, 12]. Studies have shown that there is formation 
Figure 2. 
Structures of compound present in T. chebula (1–14).
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of urolithin A, B, and C by human gut microbiota when an ellagitannin-rich diet was 
given, and also these urolithins significantly inhibited TNF-α production. The most 
potent urolithin A inhibition was observed at nanomolar concentrations (at 0.625 μM 
29.2 ± 6.4% of inhibition). Urolithin C was the only compound inhibiting IL-6 produc-
tion (at 0.625 μM 13.9 ± 2.2% of inhibition) [16]. These studies clearly indicate that 
ellagitannin-rich plant material extract has a good effect on gut microbiota. A combina-
tion of the ellagitannin metabolites found in the colon, urolithins and ellagic acid, at 
concentrations achievable in the intestine after the consumption of pomegranate, was 
able to moderately improve the inflammatory response of colon fibroblasts and suggest 
that consumption of ellagitannin-containing foods has potential beneficial effects on 
gut inflammatory diseases [17]. Effectiveness of polyphenols in dysbiosis and colon-
related diseases mainly depends on their stability, absorption, and bioavailability and 
the gut microbiota composition [18]. Encapsulation technologies could be promising 
tools to improve bioavailability and bio-accessibility of polyphenols. In recent studies, 
several micro- and nano-encapsulation systems have been proposed for specific delivery 
of individual polyphenols or mixtures of polyphenols (food ingredients) in the gut [19].
2.3 Flavonoid glycosides and aglycones
Flavonoid glycosides and phenolic glycosides are the other class of phytocon-
stituents that are extracted in substantial amount during the boiling of plants 
during preparation of formulation. These were evident when formulations like 
Figure 3. 
Possible changes during fermentation in Abhayarishta.
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Jirakadyarishta and Parthadyarishta were analyzed for standardization purpose [8, 
9]. The chemical constituents that are present in cumin seeds (major plant material 
in Jirakadyarista) are water-soluble flavonoid glycosides luteolin 4′-O-glucoside 
7-O-galacturonoside (15), apigenin-7′-digalactouronoside (16), luteolin 
7-O-glucoside (17), apigenin 7-O-glucoside (18), flavonoid aglycones luteolin (19), 
apigenin (20), sesquiterpene lactone glucosides, cuminoside A (21) and cuminoside 
B (22), cumic acid (23), cuminyl alcohol (24), glycosides of 2-C-methyl-D erythri-
tol, alkyl glucosides, and various monoterpene glycosides [20–25].
RP-HPLC analysis of the decoction and the final processed formulation revealed 
that luteolin 4′-O-glucoside 7-O-galactouronoside (15) and luteolin 4´-O-glucoside 
7-O-galactouronoside (16a) were the two major constituents of the decoction of 
C. cyminum. Selective hydrolysis of 7-O-glucosides of luteolin and apigenin during 
fermentation resulted in an increase in the amount of luteolin and apigenin in the 
final processed formulation. The 4′-O-glucoside-7-O-galacturonide of luteolin and 
galacturonide derivative of apigenin was not hydrolyzed during fermentation [9]. 
An increase in luteolin and apigenin concentration is also good for the gut health as 
recent studies have shown that flavonoids participate in the regulation of intestinal 
tight junction barrier integrity and that this regulation may partially contribute to the 
flavonoid-mediated biological effects on our health [26]. Dietary flavonoids are often 
transformed before absorption, and this transformation modulates their biological 
activity. Health benefits from this aglycone consumption should be attributed to their 
bioactive metabolites and also to the modulation of the intestinal bacterial population 
[27]. Flavonoids are the major constituents in the formulation, and various beneficial 
actions of flavonoids at the GI have been demonstrated through various reports, for 
example, (i) protection of the intestinal epithelium against pharmacological insults and 
food toxins and (ii) modulation of the activity of enzymes involved in lipid and carbo-
hydrate absorption. Thus, they maintain the intestinal barrier integrity and modulate 
the secretion of gut hormones and finally modulate the GI tract immune system. They 
also have been shown to exert potential anti-colorectal cancer activity by shaping 
microbiota composition and function. The understanding of the mechanisms mediat-
ing the effects of flavonoids on the intestine (and its microbiota) is further required for 
the widespread recommendations of increasing the intake of plant bioactives [28].
Further, the addition of Woodfordia fruticosa for augmenting fermentation 
also adds flavonoid glycosides to the formulation in major quantity, as evident 
in the studies done on Parthadyarishta, where flavonoid aglycones quercetin and 
kaempferol were produced as fermentation products from flavonoid glycosides of 
Woodfordia fruticosa [8]. Thus these flavonoid glycosides and aglycones are present 
in substantial quantity in these formulations and have well-reported protective 
actions against the IBD through various mechanisms.
2.4 5-Hydroxymethyl furfuraldehyde (5-HMF)
5-Hydroxymethyl furfuraldehyde, 5-HMF (25), is another major constituent 
which is ought to be present in this class of formulation as per the analysis done for 
the selected formulations. 5-HMF is also present in decoction of fruits and flowers 
(V. vinifera and M. indica) used for preparation of fermented preparations. Another 
source for 25 in final processed formulation is jaggery and honey which is added in a 
substantial amount to augment fermentation (Figures 1 and 4). 5 -HMF is the major 
compound extracted during boiling and forms the major constituent in the formula-
tion and is also reportedly formed under acidic conditions from fructose [29]. There 
was an enormous increase in amount of 5-HMF (25) in formulation as compared 
with decoction. The concentration of 25 needs proper monitoring in this class of 
formulations as recent reports suggest it to be genotoxic and cytotoxic [30].  
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Further, Maillard reaction product components, namely, 5-hydroxymethyl furfural 
and 5-hydroxymethyl-2-furoic acid (HMFA), were shown to have bioactive poten-
tial, especially in regard to suppressing oxidative stress and inflammation in IFN-
γ- and PMA-induced Caco-2 cells [31]. 5-Hydroxymethyl furfural (HMF)–cysteine 
adduct, 1-dicysteinethioacetal–5-hydroxymethyl furfural (DCH), promoted the 
growth of Lactobacillus, Tyzzerella, Enterobacter, and Streptococcus and also increased 
Figure 4. 
Water-soluble constituents in cumin Cuminum cyminum seeds.
Figure 5. 
5-HMF(25) as major constituent in fermented preparation.
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the ratio of Firmicutes/Bacteroidetes and promoted the growth of Akkermansia, 
Shigella, and Escherichia while inhibiting the growth of Lactobacillus [32]. Thus these 
reports are suggestive of their usage in controlling IBD (Figure 5).
2.5 Bioactives present in jaggery
Jaggery constitutes a major part in this class of formulation. It is also used very 
frequently in other class of Ayurvedic formulations. Jaggery is traditionally made 
Figure 6. 
Flavonoid glycosides in sugarcane juice: (27–38).
9Review and Implications of Traditional Indian Medicine for Inflammatory Bowel Disease
DOI: http://dx.doi.org/10.5772/intechopen.89465
by boiling sugarcane juice to solid [33]. A review of chemistry of sugarcane juice 
and its products reveals that they are rich in phenolics, phenolic glycosides, and  
flavonoid glycosides (Figure 6), namely, diosmetin-8-C-glucoside (26), 
tricin-7-O-neohesperidoside (27), 4′,5′-dimethoxy-luteoline-8-C-glucoside (28), 
tricin-7-O-rhamnosylgalacturonide (29), tricin-7-O-glucoside (30), schaftoside 
(31), isoschaftoside (32), vitexin (33), and orientin (34). Four minor flavones 
swertisin (35), tricin-7-O-neohesperoside-4’-O-rhamnoside (36), tricin-7-O-
methylglucuronate-4’-O-rhamnoside (37), and tricin-7-O-methylglucuronide (38) 
were isolated and identified from sugarcane juice [34–39]. There are health benefits 
from phenolic consumption, mainly attributed to their bioactive metabolites and 
also to the modulation of the intestinal bacterial population. Phenolic contents of 
the herbal preparation can be increased as a consequence of fermentation, and a 
positive correlation between polyphenols and the antioxidant activities of herbs has 
been well demonstrated. This is in agreement with evidence showing fermentation-
mediated enhancement of the pharmacological properties and therapeutic effica-
cies of herbal formulations against a number of diseases including obesity and 
inflammation [27].
3. Conclusions
From the evidences cited above, it is very clear that herbal formulations and 
their analysis for the presence of bioactive constituents are important as far as 
their efficacy is concerned. Three formulations have been cited, and major con-
stituents present in them have proven to be good agents for IBD. Natural products 
and herbal medicine formulas have exhibited efficacy in preclinical evaluation, 
improved symptoms, and decreased medical costs for IBD patients. The compo-
nents of natural products and herbs are complex and have multiple mechanisms 
of action that may synergize to produce their overall efficacy. Intensive studies 
based on murine models of IBD and human studies are required for evaluating 
the efficacy of natural products and herbal medicine as an alternative treatment 
for IBD. Thus identification of the active component(s) and optimization of the 
dosage and development of treatment protocol(s) are of primary importance. The 
modern hyphenated techniques having high-throughput technologies shall enable 
the identification of the effective ingredient(s) and reveal the mechanisms of 
action of natural products and herbs in treating IBD. Natural products and herbal 
formulations (as co-adjuvants) with existing medications may also provide new 
therapy options for IBD patients.
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